Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries-Reference-Cited by-同舟云学术

Determinants of first- and second-generation antipsychotic drug use in clinically unstable patients with schizophrenia treated in four European countries

Published:2006-03 Issue:2 Volume:21 Page:73-79
ISSN:0268-1315
Container-title:International Clinical Psychopharmacology
language:en
Short-container-title:

Author:

Barbui Corrado,Nosè Michela,Mazzi Maria Angela,Bindman Jonathan,Leese Morven,Schene Aart,Becker Thomas,Angermeyer Matthias C.,Koeter Maarten,Gray Richard,Tansella Michele

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Pharmacology (medical),Psychiatry and Mental health

Reference40 articles.

1. Specificity of the Calgary Depression Scale for schizophrenics;Addington;Schizophr Res,1994

2. Reliability and validity of a depression rating scale for schizophrenics;Addington;Schizophr Res,1992

3. Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy;Andretta;Soc Psychiatry Psychiatr Epidemiol,2005

4. Hospital use of antipsychotic agents in 1989 and 1993: stable dosing with decreased length of stay;Baldessarini;Am J Psychiatry,1995

5. The measurement of problem drinking in young adulthood;Baley;J Stud Alcohol,1999

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical determinants, patterns and outcomes of antipsychotic medication prescribing in the treatment of schizophrenia and schizoaffective disorder: A naturalistic cohort study;Journal of Psychiatric Research;2023-02

2. Effects of antipsychotic drugs on cardiovascular variability in participants with bipolar disorder;Human Psychopharmacology: Clinical and Experimental;2014-01-03

3. Poor Adherence to Antipsychotic Medication in People with Schizophrenia: Diffusion, Consequences and Contributing Factors;Adherence to Antipsychotics in Schizophrenia;2013-11-28

4. Antipsychotic Polypharmacy;Psychiatric Clinics of North America;2012-09

5. Determinants of treatment satisfaction of schizophrenia patients: Results from the ESPASS study;Schizophrenia Research;2012-08